Today's Hours: 8:00am - 6:00pm


Filter Applied Clear All

Did You Mean:

Search Results

  • Book
    June M. McKoy, Dennis P. West, editors.
    Summary: Cancer Policy: Pharmaceutical Safety provides invaluable information on the interesting and compelling field of cancer drug safety. Identifying and understanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chapters provide an overview and synthesis of the latest thoughts and findings relating to drug safety in the cancer domain. Topics include natural language processing and pharmacovigilance of alternative cancer pharmaceuticals. The information presented in this volume will improve understanding of emerging strategies to identify adverse drug reactions and drug-drug interactions within the cancer setting and will highlight policies that have been instituted to improve cancer patient safety. In summary, Cancer Policy: Pharmaceutical Safety explores many of the important areas of pharmacovigilance research in oncology.

    1. Impact of cost on the safety of cancer pharmaceuticals
    2. Cancer comorbidity: implications for drug safety
    3. Pharmacovigilance of alternative medications in the cancer setting
    4. Key elements in adverse drug reactions safety signals: application of legal strategies
    5. Biosimilars: are they really safe?
    6. The drug shortage crisis in the United States: impact on cancer pharmaceutical safety
    7. Anatomy of risk evaluation and mitigation strategies (REMS)
    8. Cancer drug toxicity: moving from patient to survivor
    9. Moonshot to cancer cure: recruiting policy to break down silos.
    Digital Access Springer 2019
    Print Access Request
    Call Number
    Books: General Collection (Downstairs)
    RM301 .C36 2019